Reports From the Field: White paper addresses HIPAA concerns and DM
Reports From the Field: White paper addresses HIPAA concerns and DM
A comprehensive analysis of the Health Insurance Portability and Accountability Act (HIPAA) and its impact on disease management has concluded that the new privacy regulations will not hamper disease management programs, according to the Disease Management Association of America (DMAA).
The association’s White Paper concluded that the Department of Health and Human Services has fully safeguarded the ability of legitimate disease management programs to use and disclose protected health information for activities within the DMAA’s industry consensus of disease management.
These include enrolling and engaging patients, teaching patients self-management, coordinating care, providing medication compliance guidelines and reminders, publishing outcomes data, conducting population management and risk stratification, supporting physicians and the plan of care, and promoting other disease management and population management services.
"While a lot of things in HIPAA are still unclear, disease management is not one of them. The White Paper’s legacy will be to eliminate any concern that disease management cannot coexist with strong patient privacy protections, that disease manager somehow hinder or is hindered by privacy. Neither is true, and this initiative finally proves it," says Warren Todd, DMAA’s executive director.
The document may be obtained free from DMAA. See the web site at www.dmaa.org.
Order your smallpox vaccination handbook today
Call today for your copy of Hospital Handbook on Smallpox Vaccination, a facilitywide resource containing all the information you need about smallpox vaccination in most health care facilities and environments. Learn about possible side effects and adverse reactions and how to protect your staff, patients, and family members against this most controversial vaccine. Read about the challenges of implementing a smallpox care team plus critical staffing and screening issues that will affect your entire facility as well as crucial questions about liability and other legal concerns.
This newly released handbook confronts the implications that departments face throughout the hospital, including infection control, the ED, critical care, employee health, and risk management.
Order your copy today of this comprehensive resource guaranteed to provide you with the knowledge you need to manage this unprecedented response to a bioterrorism threat. The cost is just $99 for subscribers who will receive a discount off the original price of $149. To order, call customer service at (800) 688-2421. When ordering, please refer to the effort code: 76991.
A comprehensive analysis of the Health Insurance Portability and Accountability Act (HIPAA) and its impact on disease management has concluded that the new privacy regulations will not hamper disease management programs, according to the Disease Management Association of America (DMAA).Subscribe Now for Access
You have reached your article limit for the month. We hope you found our articles both enjoyable and insightful. For information on new subscriptions, product trials, alternative billing arrangements or group and site discounts please call 800-688-2421. We look forward to having you as a long-term member of the Relias Media community.